Advertisement
Singapore markets closed

  • Straits Times Index

    3,410.81
    -29.07 (-0.85%)
     

  • Nikkei

    40,912.37
    -1.28 (-0.00%)
     

  • Hang Seng

    17,799.61
    -228.67 (-1.27%)
     

  • FTSE 100

    8,203.93
    -37.33 (-0.45%)
     

  • Bitcoin USD

    56,497.10
    -1,667.15 (-2.87%)
     

  • CMC Crypto 200

    1,173.48
    -35.21 (-2.91%)
     

  • S&P 500

    5,567.19
    +30.17 (+0.54%)
     

  • Dow

    39,375.87
    +67.87 (+0.17%)
     

  • Nasdaq

    18,352.76
    +164.46 (+0.90%)
     

  • Gold

    2,396.90
    +27.50 (+1.16%)
     

  • Crude Oil

    83.12
    -0.76 (-0.91%)
     

  • 10-Yr Bond

    4.2720
    -0.0830 (-1.91%)
     

  • FTSE Bursa Malaysia

    1,611.02
    -5.73 (-0.35%)
     

  • Jakarta Composite Index

    7,253.37
    +32.48 (+0.45%)
     

  • PSE Index

    6,492.75
    -14.74 (-0.23%)
     

MannKind: Q1 Earnings Snapshot

Associated Press Finance
·1-min read

DANBURY, Conn. (AP) — DANBURY, Conn. (AP) — MannKind Corp. (MNKD) on Wednesday reported first-quarter earnings of $10.6 million.

The Danbury, Connecticut-based company said it had profit of 4 cents per share. Earnings, adjusted for stock option expense and non-recurring costs, came to 5 cents per share.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 2 cents per share.

The biopharmaceutical company posted revenue of $66.3 million in the period, which also topped Street forecasts. Three analysts surveyed by Zacks expected $58.2 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MNKD at https://www.zacks.com/ap/MNKD